Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wrapp

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Plos Pathogens|August 4, 2020
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment stepXiaohua Ye, Hang Su, Daniel Wrapp, et al.
Cell|June 13, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
Science Immunology|February 24, 2021
Prolonged evolution of the human B cell response to SARS-CoV-2 infectionMrunal Sakharkar, C Garrett Rappazzo, Wendy F Wieland-Alter, et al.
Communications Biology|December 31, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Plos Pathogens|January 20, 2023
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirusJennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Science Advances|March 11, 2022
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodiesDaniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blockingAndrea R Shiakolas, Nicole Johnson, Kevin J Kramer, et al.
Research Square|November 16, 2022
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroupsGeoffrey Hutchinson, Olubukola Abiona, Cynthia Ziwawo, et al.
Science Translational Medicine|May 5, 2017
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infantsQing Zhu, Jason S McLellan, Nicole L Kallewaard, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Plos Pathogens|August 4, 2020
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment stepXiaohua Ye, Hang Su, Daniel Wrapp, et al.
Cell|June 13, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
Science Immunology|February 24, 2021
Prolonged evolution of the human B cell response to SARS-CoV-2 infectionMrunal Sakharkar, C Garrett Rappazzo, Wendy F Wieland-Alter, et al.
Communications Biology|December 31, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Plos Pathogens|January 20, 2023
A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirusJennifer A Jenks, Sharmi Amin, Madeline R Sponholtz, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Science Advances|March 11, 2022
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodiesDaniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blockingAndrea R Shiakolas, Nicole Johnson, Kevin J Kramer, et al.
Research Square|November 16, 2022
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroupsGeoffrey Hutchinson, Olubukola Abiona, Cynthia Ziwawo, et al.
Science Translational Medicine|May 5, 2017
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infantsQing Zhu, Jason S McLellan, Nicole L Kallewaard, et al.
Pageof 7